Root Admin Guide Posted May 23, 2011 Root Admin Report Share Posted May 23, 2011 A recently published clinical trial which is described as a "12-week, open-label, community-based, phase 4 trial of 1421 participants is the largest study of the disease to date" entitled, "The ORCA (Oracea® for Rosacea: A Community-Based Assessment) Trial: A Large-Scale, Phase 4 Trial in Papulopustular Rosacea," concluded "the effectiveness and safety of the 40-mg formulation of doxycycline in patients with papulopustular rosacea." Cutis Supplement Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now